GPS for the prostate: 3D navigation aims to cut surgery risks

NCT ID NCT07251621

Completed Symptom relief Sponsor: Chinese PLA General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a 3D imaging navigation system to help guide HoLEP surgery for benign prostate enlargement. 150 men were split into two groups: one with the navigation system and one without. The goal was to see if the system reduces complications like urine leakage and urethral narrowing. The system combines MRI scans with real-time ultrasound to show the surgeon exactly where instruments are inside the prostate.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 3D imaging-assisted surgical navigation system
What this could lead to: If successful, this navigation system could make prostate surgery safer and reduce side effects like urine leakage.
What could go wrong: This is a small, completed trial with no blinding, so results may be influenced by bias. The system may not work as well in other hospitals or for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATE HYPERTROPHY(BPH)

Contacts and locations

Locations

ChinaPLAGH

Beijing, Haidian, 100039, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.